Author Topic: Studies on efficacy of HCQ on COVID-19 must employ HCQ+AZ+ZINC to be of value  (Read 1404 times)

admin

  • Administrator
  • Hero Member
  • *****
  • Posts: 3090
Studies on efficacy of HCQ for COVID-19 must employ zinc+hydroxychloroquine+azythromycin to be of value (zinc is what ultimately kills the virus), and the therapy must be administered as early as possible, upon the presentation of COVID-19 symptoms or suspicion of COVID. Tests are so unreliable test results should not be waited for or depended upon to make a clinical treatment decision, since waiting a couple days for a result is time that the COVID19 patient may not have, and a false negative test could wind up costing an elderly or high risk patient their life. One doctor who was COVID positive, tested negative 5 times, before he tested positive.

This is a doctor that started treatment upon suspicion of symptoms, which is the way perhaps thousands of doctors all around the world, are treating this disease.



Note when this doctor began treatment on frail elderly (COVID positive) patients in a nursing home environment - as soon as there was a slight reduction in blood oxygen.


« Last Edit: November 03, 2020, 05:54:45 AM by admin »
www.covidtreatmentoptions.com/
Over a million Americans died completely unnecessary, horrific, deaths from COVID-19. Do you have a plan in place to help your family dodge the average $73,300 COVID hospital bill, through prevention and $20 EARLY treatment? https://www.covidtreatment